clopidogrel and s 1743

clopidogrel has been researched along with s 1743 in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (17.95)	29.6817
2010's	30 (76.92)	24.3611
2020's	2 (5.13)	2.80

Authors

Authors	Studies
Chan, FK; Chan, HL; Ching, JY; Chung, SC; Hui, AJ; Hung, LC; Kung, NN; Lau, JY; Lee, KK; Lee, VW; Lee, YT; Leung, VK; Leung, WK; Sung, JJ; To, KF; Wong, VW; Wu, JC	1
Mössner, J; Nitschmann, S	1
Archimandritis, A; Cokkinos, D; Elisaf, MS; Kiskinis, D; Liberopoulos, EN; Mikhailidis, DP; Tselepis, AD	1
Chan, AO; Chu, KM; Fung, TT; Hu, WH; Hui, WM; Hung, WK; Kwok, KF; Lai, KC; Lam, SK; Loo, CK; Wong, BC; Wong, J	1
Johansen, M	1
Christ, G; Jilma, B; Kreiner, G; Lang, IM; Siller-Matula, JM; Spiel, AO	1
Braun, S; Hadamitzky, M; Kastrati, A; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Vogt, W; von Beckerath, N	1
Binkley, P; Donnally, MR; Evanchan, J; Mazzaferri, E	1
Börgel, J; Endres, HG; Engelhardt, A; Krüger, JC; Lask, S; Mügge, A; Neubauer, H	1
Hsu, PI; Lai, KH; Liu, CP	1
Deneer, VH; Hackeng, CM; Harmsze, AM; Taubert, D; van Werkum, JW	1
Bassler, N; Dart, AM; Fernando, H; Habersberger, J; Peter, KH; Sharma, R; Shaw, JA; Sheffield, LJ	1
Boot, H; de Boer, A; Deneer, VH; Harmsze, AM; Heringa, M; le Comte, M; Mol, PG; Schalekamp, T; Verduijn, MM; Verheugt, FW	1
Cerboni, P; Doyen, D; Ferrari, E; Moceri, P	1
Buckley, DB; Kazmi, F; Ogilvie, BW; Paris, BL; Parkinson, A; Rostami-Hodjegan, A; Toren, P; Yerino, P	1
Htun, WW; Huang, Y; Ko, W; Kwan, J; Kwan, TW	1
Chen, PF; Hsiao, FY; Huang, WF; Mullins, CD; Tsai, YW; Wen, YW	1
Chan, FK; Lam, KF; Lau, YK; Ng, FH; Tunggal, P	1
Chan, K; Chu, WM; Keung, KK; Kng, C; Kwan, A; Lam, KF; Lau, YK; Li, A; Ng, FH; Tunggal, P; Wong, BC	1
Kwok, CS; Loke, YK	1
Bhatt, DL; Brooks, JK; Frelinger, AL; Lee, RD; Michelson, AD; Mulford, DJ; Nigam, A; Nudurupati, S; Wu, J	1
Banahan, BF; Bentley, JP; Datar, MV; Mahabaleshwarkar, RK; Null, KD; Strum, MW; Yang, Y	1
Alam, S; El-Halabi, MM; Ghaith, OA; Mahfouz, R; Malli, A; Mansour, NM; Sharara, AI; Zgheib, N	1
Andersson, T; Galbraith, H; Nagy, P; Niazi, M; Nylander, S; Ranjan, S; Wallentin, L	1
Bertino, JS	1
Bilker, WB; Brensinger, CM; Flockhart, DA; Freeman, CP; Hennessy, S; Kasner, SE; Kimmel, SE; Leonard, CE	1
Akasaka, T; Arima, Y; Hokimoto, S; Kaikita, K; Kumagae, N; Morita, K; Nakagawa, K; Ogawa, H; Oniki, K; Sakamoto, K; Tabata, N; Tsujita, K; Yamamoto, E	1
Cheng, K; Guo, WY; Liu, LP; Si, R; Wang, Y; Yuan, M	1
Bayon, J; Carrillo, P; CruzGonzalez, I; de la Torre Hernandez, JM; de Leiras, SR; Fernandez-Fernandez, J; Fernandez-Portales, J; Gomez-Jaume, A; Gopar-Gopar, S; Hernandez, F; Lasa, G; Lozano, I; Mañas, P; Pérez-Serradilla, A; Pinar, E; Ruiz-Quevedo, V; Sanchez-Insa, E	1
Barbeau, G; Bertrand, OF; De Larochellière, R; Déry, JP; Déry, U; Gleeton, O; Harvey, A; Larose, É; Modak, A; Nguyen, CM; Noël, B; Paradis, JM; Proulx, G; Rinfret, S; Rodés-Cabau, J; Roy, L; Roy, M	1
Grove, EL; Würtz, M	1
Furuta, T; Hamaya, Y; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Umemura, K; Uotani, T; Yamade, M	1
Czerniak, R; Nishihara, M	1
Furuta, T; Kagami, T	1
Higashi, T; Inoue, R; Mitsutake, T; Morinaga, Y; Nii, K	1
Chen, C; Huang, S; Lin, D; Luo, Y; Wu, Y; Yu, W	1
Denda, M; Goda, M; Hamano, H; Higashionna, T; Ishizawa, K; Lin, TJ; Miyata, K; Nawa, H; Neishi, M; Niimura, T; Yagi, K; Zamami, Y	1
Häyrynen, S; Kiiski, JI; Niemi, M; Ramste, M; Ritvos, M; Sinisalo, J	1

Reviews

4 review(s) available for clopidogrel and s 1743

Article	Year
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now? Platelets, 2006, Volume: 17, Issue:1 Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2006
[Interaction between clopidogrel and proton pump inhibitors]. Nederlands tijdschrift voor geneeskunde, 2011, Volume: 155, Issue:28 Topics: Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2011
Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review. Drug safety, 2012, Feb-01, Volume: 35, Issue:2 Topics: Blood Platelets; Clopidogrel; Drug Interactions; Esomeprazole; Humans; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine	2012
Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs. Advances in experimental medicine and biology, 2017, Volume: 906 Topics: Adenosine; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Administration Schedule; Drug Dosage Calculations; Drug Interactions; Esomeprazole; Gastrointestinal Hemorrhage; Gene Expression; Humans; Hydrogen-Ion Concentration; Peptic Ulcer; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine	2017

Trials

12 trial(s) available for clopidogrel and s 1743

Article	Year
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. The New England journal of medicine, 2005, Jan-20, Volume: 352, Issue:3 Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine	2005
Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2006, Volume: 4, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Clopidogrel; Cohort Studies; Double-Blind Method; Esomeprazole; Female; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Secondary Prevention; Stomach Ulcer; Ticlopidine; Treatment Outcome	2006
Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting. Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Regression Analysis; Stents; Ticlopidine	2010
Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis. Gastroenterology, 2011, Volume: 140, Issue:3 Topics: Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Atherosclerosis; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Endoscopy, Gastrointestinal; Esomeprazole; Female; Genotype; Humans; Male; Middle Aged; Peptic Ulcer; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Secondary Prevention; Taiwan; Ticlopidine; Time Factors; Treatment Outcome	2011
Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel. Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:8 Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Phenotype; Phosphoproteins; Placebo Effect; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Risk Assessment; Ticlopidine; Time Factors; Victoria	2011
Doubling the dose of clopidogrel restores the loss of antiplatelet effect induced by esomeprazole. Thrombosis research, 2011, Volume: 128, Issue:5 Topics: Aged; Anti-Ulcer Agents; Aspirin; Clopidogrel; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ranitidine; Ticlopidine	2011
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial. American heart journal, 2011, Volume: 162, Issue:5 Topics: Acute Coronary Syndrome; Anti-Ulcer Agents; Blood Platelets; Clopidogrel; Double-Blind Method; Esomeprazole; Famotidine; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome	2011
Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. The American journal of gastroenterology, 2012, Volume: 107, Issue:3 Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Esomeprazole; Famotidine; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticlopidine; Treatment Outcome	2012
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. Journal of the American College of Cardiology, 2012, Apr-03, Volume: 59, Issue:14 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Blood Coagulation; Blood Platelets; Clopidogrel; Confidence Intervals; Cross-Over Studies; Dexlansoprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Reference Values; Ticlopidine; Young Adult	2012
Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014, Volume: 14, Issue:3 Topics: Adolescent; Adult; Area Under Curve; Aspirin; Clopidogrel; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Healthy Volunteers; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Platelet Aggregation; Proton Pump Inhibitors; Ticlopidine; Young Adult	2014
Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:1 Topics: Aged; Aspirin; Case-Control Studies; Cell Adhesion Molecules; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Microfilament Proteins; Middle Aged; Percutaneous Coronary Intervention; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ticlopidine	2016
Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity. Journal of breath research, 2016, Jan-27, Volume: 10, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Blood Platelets; Breath Tests; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Humans; Omeprazole; Pantoprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Ranitidine; Ticlopidine	2016

Other Studies

23 other study(ies) available for clopidogrel and s 1743

Article	Year
[ASS or clopidogrel plus esomeprazole after bleeding from an ulcer]. Der Internist, 2005, Volume: 46, Issue:12 Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine	2005
[Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Nov-02, Volume: 126, Issue:21 Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Esomeprazole; Evidence-Based Medicine; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Ticlopidine	2006
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. American heart journal, 2009, Volume: 157, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Blood Platelets; Clopidogrel; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2009
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thrombosis and haemostasis, 2009, Volume: 101, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Stents; Ticlopidine	2009
Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction. Clinical cardiology, 2010, Volume: 33, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angioplasty, Balloon, Coronary; Anti-Ulcer Agents; Clopidogrel; Confidence Intervals; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Pantoprazole; Patient Readmission; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Failure	2010
Esomeprazole but not pantoprazole is associated with lower plasma concentrations of clopidogrel's active metabolite. The Annals of pharmacotherapy, 2011, Volume: 45, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Clopidogrel; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Female; Humans; Male; Middle Aged; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine	2011
The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Hepatocytes; Humans; Inhibitory Concentration 50; Lansoprazole; Microsomes; Microsomes, Liver; Omeprazole; Pantoprazole; Protein Binding; Proton Pump Inhibitors; Recombinant Proteins; Ticlopidine	2011
Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention. Vascular health and risk management, 2011, Volume: 7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Asian; Asian People; Blood Platelets; China; Clopidogrel; Drug Resistance; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; New York City; Omeprazole; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Stents; Thrombosis; Ticlopidine; Time Factors	2011
Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome. Pharmacoepidemiology and drug safety, 2011, Volume: 20, Issue:10 Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Databases, Factual; Drug Interactions; Esomeprazole; Female; Herb-Drug Interactions; Hospitalization; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Ticlopidine; Treatment Outcome	2011
Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients. Current medical research and opinion, 2013, Volume: 29, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Artery Bypass; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Myocardial Infarction; Omeprazole; Pantoprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Rabeprazole; Risk; Stroke; Ticlopidine	2013
CYP2C19 genetic polymorphism, rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel. Journal of cardiovascular pharmacology, 2013, Volume: 62, Issue:1 Topics: Aged; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Esomeprazole; Female; Genotype; Humans; In Vitro Techniques; Logistic Models; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ticlopidine	2013
The clopidogrel conundrum. Journal of clinical pharmacology, 2014, Volume: 54, Issue:8 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Drug Interactions; Esomeprazole; Genotype; Humans; Omeprazole; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome	2014
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Stroke, 2015, Volume: 46, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Data Interpretation, Statistical; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proportional Hazards Models; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Risk; Stroke; Ticlopidine	2015
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy. Thrombosis research, 2015, Volume: 135, Issue:6 Topics: Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Esomeprazole; Ethnicity; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome	2015
Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel. The American journal of cardiology, 2016, Feb-01, Volume: 117, Issue:3 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome	2016
Drug interaction: Clopidogrel and PPIs. The Medical letter on drugs and therapeutics, 2017, 02-27, Volume: 59, Issue:1515 Topics: Clopidogrel; Drug Interactions; Esomeprazole; Humans; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Ticlopidine	2017
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype. Clinical pharmacology and therapeutics, 2018, Volume: 103, Issue:5 Topics: Adult; Asian People; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Female; Genotype; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrroles; Sulfonamides; Young Adult	2018
CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan. Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:1 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Genotype; Prasugrel Hydrochloride; Pyrroles; Sulfonamides	2018
Response to "CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan". Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:1 Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Genotype; Prasugrel Hydrochloride; Pyrroles; Sulfonamides	2018
Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy. Clinical drug investigation, 2019, Volume: 39, Issue:10 Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Thromboembolism	2019
The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019, Volume: 28, Issue:11 Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Esomeprazole; Famotidine; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Treatment Outcome	2019
Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases. Toxicology and applied pharmacology, 2023, 09-15, Volume: 475 Topics: Adverse Drug Reaction Reporting Systems; Cilostazol; Clopidogrel; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Esomeprazole; Hemorrhage; Humans; Omeprazole; Prasugrel Hydrochloride; United States	2023
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel. Clinical and translational science, 2023, Volume: 16, Issue:10 Topics: Alleles; Clopidogrel; Cytochrome P-450 CYP2C19; Esomeprazole; Genotype; Humans; Omeprazole; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Treatment Outcome	2023